Mina et al. used IL-1β receptor antagonist to antagonize IL-1β, which reversed BBB damage and cognitive impairment after brain oxidative damage, confirming that IL-1β is an important factor mediating cognitive impairment in sepsis (Mina et al., 2014). Here, IL1B is linked to Cognitive impairment.